Study links gene with DiGeorge heart defects:
This article was originally published in Clinica
A US team has discovered a critical gene responsible for cardiovascular defects in patients with DiGeorge Syndrome, a hereditary condition claimed to be the second leading cause of heart disease in children. The discovery of the gene, called Tbx1, paves the way for prenatal testing for a defect associated with the gene, thus opening the door to treatment at birth or to the new surgical techniques developed for patients still in the womb. The finding is described by researchers from the University of Pennsylvania Medical Center and Albert Einstein College of Medicine in the journal Cell (February 23).
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.